Zurich Insurance Group’s Xylem XYL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-306,254
Closed -$45.2M 338
2025
Q3
$45.2M Buy
+306,254
New +$42.5M 0.32% 80
2022
Q3
Sell
-12,500
Closed -$977K 265
2022
Q2
$977K Buy
+12,500
New +$1.03M 0.01% 201
2019
Q4
Sell
-33,225
Closed -$2.65M 492
2019
Q3
$2.65M Buy
+33,225
New +$2.61M 0.05% 333
2018
Q4
Sell
-106,583
Closed -$8.51M 529
2018
Q3
$8.51M Buy
+106,583
New +$7.96M 0.18% 154
2018
Q2
Sell
-40,911
Closed -$3.15M 552
2018
Q1
$3.15M Buy
40,911
+16,045
+65% +$1.19M 0.07% 328
2017
Q4
$1.7M Sell
24,866
-19,194
-44% -$1.27M 0.04% 446
2017
Q3
$2.76M Buy
44,060
+8,493
+24% +$508K 0.08% 296
2017
Q2
$1.97M Buy
35,567
+10,284
+41% +$536K 0.06% 399
2017
Q1
$1.27M Buy
25,283
+366
+1% +$17.8K 0.04% 423
2016
Q4
$1.23M Buy
+24,917
New +$1.26M 0.04% 385

Other funds holding XYL

Zurich Insurance Group's XYL Position: Q4 2025 in Review

Zurich Insurance Group sold out of Xylem (XYL) in Q4 2025, closing a stake of 306,254 shares — an estimated $45.2M sold.

Zurich Insurance Group first reported a position in XYL in Q4 2016 and held it in 10 quarters. The position peaked at $45.2M in Q3 2025. 1,130 funds tracked by Wall St. Rank hold XYL as of Q4 2025.

  • Zurich Insurance Group reported no remaining Xylem position as of Q4 2025 after selling out during the quarter.
  • Zurich Insurance Group sold 306,254 Xylem shares in Q4 2025, an estimated $45.2M.
  • Zurich Insurance Group first reported a position in Xylem in Q4 2016 and held it in 10 quarters.
  • Zurich Insurance Group's Xylem position peaked at $45.2M in Q3 2025.
  • 1,130 funds tracked by Wall St. Rank held Xylem as of Q4 2025.

Based on Zurich Insurance Group's 13F filing for Q4 2025, filed 17 Feb 2026.